Advertisements


FDA approves Alnylam"s Onpattro as hATTR treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

FDA Approves $450,000-a-Year Treatment for Rare Disease

Patients who have hereditary transthyretin-mediated amyloidosis, or hATTR, will take the drug for the rest of their lives. Alnylam Phar.....»»

Category: europeSource: fortuneAug 11th, 2018

Alnylam confirms FDA approves Onpattro to treat polyneuropathy caused by hATTR

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam"s Onpattro approved by FDA to treat polyneuropathy caused by hATTR

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Akorn"s stock soars after FDA approves ANDA for hypotrichosis of eyelashes treatment

Shares of Akorn Inc. ran up 13% in premarket trade Wednesday, putting them on track for a seventh-straight gain, after the .....»»

Category: topSource: marketwatchOct 10th, 2018

Alnylam"s Onpattro highly efficacious, safer than competitor, says Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 7th, 2018

FDA approves Akcea, Ionis treatment Tegsedi

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 5th, 2018

FDA Approves Paratek"s Bacterial Pneumonia, Skin Infection Treatment

Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) shares reacted positively following the announcement of a Food and Drug Administration's approved treatment. read more.....»»

Category: blogSource: benzingaOct 3rd, 2018

Alnylam launches ONPATTRO in Germany

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 2nd, 2018

Alnylam announces submission of NDA in Japan for ONPATTRO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 28th, 2018

The Wall Street Journal: Senate approves bipartisan bill to fight opioid epidemic

The Senate on Monday passed sweeping, bipartisan legislation aimed at combating the opioid epidemic through new research, treatment and help for families affected by addiction......»»

Category: topSource: marketwatchSep 17th, 2018

Alnylam data publication points to positive Onpattro risk profile, says Cowen

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 14th, 2018

FDA approves Teva "s Cassipa for maintenance treatment of opioid dependence

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 7th, 2018

Alnylam"s Shares Up as Onpattro Gets FDA and EU Approvals

Zacks.....»»

Category: topSource: redinewsSep 5th, 2018

The FDA Approves Merck"s Anti-HIV-1 Drugs

Merck's products represent a treatment option for chronically infected adult patients in the USRelated Stocks: MRK,.....»»

Category: smallbizSource: nytAug 31st, 2018

Alnylam receives approval of ONPATTRO in Europe

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 30th, 2018

JMP says Pfizer data "impressive," but leave room for Alnylam"s Onpattro

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 28th, 2018

Ionis CRL positive for Alnylam"s Onpattro, says B. Riley FBR

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 28th, 2018

Alnylam stock rises 6% on rival treatment"s results

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchAug 27th, 2018

AbbVie: FDA approves IMBRUVICA plus RITUXAN for treatment of WM

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 27th, 2018

Roche"s Lung Cancer Drug Alecensa Gets Approval in China

The China National Drug Administration approves Roche's (RHHBY) cancer drug Alecensa as a monotherapy for first-line treatment of advanced non-small ce.....»»

Category: smallbizSource: nytAug 20th, 2018